BSE filing, NSE: INTRGLB. Summary written from the filing by ALFA Finder's alert engine.
Inter Globe Finance Ltd: key numbers
- Share price
- ₹61.00
- Market cap
- ₹82.74 Cr
- Revenue (annual)
- ₹177.9 Cr
- Net profit (annual)
- ₹2.25 Cr
- P/E (TTM)
- -266.4×Sector 19.7×
- Promoter holding
- 58.46%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Inter Globe Finance Ltd
All →Inter Globe Finance Other Announcement
Inter Globe Finance Ltd has filed its quarterly shareholding pattern report as per Regulation 31(1)(b) of the SEBI Listing Regulations.
Inter Globe Finance Annual General Meeting
Inter Globe Finance Ltd held its Annual General Meeting on September 30, 2026. Agenda items included financial statement adoption, director re-appointment, and charitable contribution authorizations.
Inter Globe Finance Annual Report
Inter Globe Finance Ltd has released its Annual Report for the financial year 2025-2026. The 33rd Annual General Meeting is scheduled for September 30, 2026.
Inter Globe Finance Annual General Meeting
Inter Globe Finance Ltd will hold its 33rd Annual General Meeting on September 30, 2026. The meeting will be conducted via video conferencing to transact ordinary and special business.
Inter Globe Finance Management Change
Inter Globe Finance Ltd appointed M/s. Shah Kothari & Associates as Internal Auditor for 12 months. The decision was finalized during the board meeting held on August 21, 2026.
- Execution
- 12 months
Inter Globe Finance Q1 FY27 Results: Net Profit ₹1.4 Cr, Down 56.2% YoY
Inter Globe Finance Ltd reported revenue from operations of ₹52.8 Cr (-21.4% YoY) and net profit of ₹1.4 Cr (-56.2% YoY) for Q1 FY27.
- Key figure
- Net profit ₹1.4 Cr · -56.2% YoY
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.